Search results
Kansas Attorney General sues Pfizer for misleading covid claims
KOAM· 1 day ago(KANSAS) -- Kansas Attorney General Kris Kobach is suing Pfizer for misleading claims made related...
FDA Tells Vaccine Makers to Target New COVID Variant for Fall
WFMZ Eastern Pennsylvania and Western New Jersey· 5 days agoCOVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot...
Gateway - Quartz
Quartz· 1 day agoThe company announced on Oct. 20 that it intends to sell the covid vaccine, marketed under the brand name Comirnaty, for $110 to $130 per dose. According ...
Gateway - Quartz
Quartz· 9 hours agoPharma giant AstraZeneca aims to increase its revenue by a whopping 75% in 2030, up from the $45.8 billion it generated in 2023 — just as it pulls its COVID-19 vaccines ...
Livelsberger Financial Advisory Acquires Shares of 4,103 Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 12 hours agoLivelsberger Financial Advisory bought a new position in shares of Pfizer Inc. (NYSE:PFE – Free Report) during the 4th quarter, according to its most recent 13F filing with ...
We Won't Solve Long COVID Until We Decide What It Is
Medscape· 20 hours agoIs a slow recovery from COVID-19 the lingering effects of a bad infection or the start of a new syndrome?
FDA advises Covid vaccine makers to target new contagious strain for fall shots
NBC Universal via AOL· 5 days agoThe FDA advised drugmakers to update Covid vaccines to target the KP.2 strain, a descendant of the...
Pfizer Inc. (NYSE:PFE) Shares Sold by CoreFirst Bank & Trust
ETF DAILY NEWS· 14 hours agoCoreFirst Bank & Trust decreased its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 2.3% during the 4th quarter, according to the company in its most recent 13F filing with ...
Pfizer Inc. (NYSE:PFE) Shares Sold by B. Riley Wealth Advisors Inc.
ETF DAILY NEWS· 14 hours agoB. Riley Wealth Advisors Inc. decreased its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 15.0% during the fourth quarter, according to its most recent 13F ...
Pfizer: An Oversold Pharma Stock in Recovery
GuruFocus.com via Yahoo Finance· 6 days agoThis combination caused a mechanical reaction of profit squeeze, which is unlikely to be sustained as inflation stabilizes and Pfizer's revenue sources...
